Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration †.

MLA

Tsujino, Kohei, et al. “Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration †.” Proceedings (2504-3900), vol. 100, May 2024, p. 15. EBSCOhost, https://doi.org/10.3390/proceedings2024100015.

APA

Tsujino, K., Kashiwagi, H., Kayama, R., Fujikawa, Y., Fukuo, Y., Hiramatsu, R., Nonoguchi, N., Takata, T., Tanaka, H., Suzuki, M., Hu, N., Wanibuchi, M., Nakai, K., Nishimura, K., Nakamura, H., & Kawabata, S. (2024). Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration †. Proceedings (2504-3900), 100, 15. https://doi.org/10.3390/proceedings2024100015

Chicago

Tsujino, Kohei, Hideki Kashiwagi, Ryo Kayama, Yoshiki Fujikawa, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, et al. 2024. “Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration †.” Proceedings (2504-3900) 100 (May): 15. doi:10.3390/proceedings2024100015.